Supplements

Post-COVID paediatric dysautonomia is best conceptualised as a distributed brain-heart-vascular network disorder rather than a primary cardiac abnormality

The paper argues that post-COVID dysautonomia in children arises from complex interactions among central autonomic network dysfunction, neurovascular dysregulation, and impaired venous return, with tachycardia representing a compensatory physiological response. Clinical phenotypes include POTS, neurocardiogenic syncope, and orthostatic intolerance, often accompanied by fatigue, cognitive dysfunction, and sleep disturbances.

Last updated: Jul 9, 2026โ€ข0 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score32/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?

observational

Das B, Moodley M ยท Cardiology in the young (2026)

Participants: N/A
Duration: N/A
Intervention: N/A (review/opinion piece)
Outcome: Conceptualisation of dysautonomia as a brain-heart-vascular network disorder
Effect Size: N/A
Population: Children and adolescents with post-COVID dysautonomia

Result:

Mechanism Graph

Central autonomic network dysfunction
โ†“
Neurovascular dysregulation and impaired venous return
โ†“
Endothelial injury and hypovolemia
โ†“
Altered cerebral perfusion leading to compensatory tachycardia

Limitations

  • โš Reported prevalence varies widely due to evolving definitions and heterogeneous referral patterns
  • โš Important gaps remain in disease definitions, mechanistic understanding, and evidence-based treatment

Frequently Asked Questions

What is post-COVID paediatric dysautonomia?โ–ผ

It is a condition in children and adolescents following COVID-19, involving dysfunction of the autonomic nervous system, presenting with symptoms like dizziness, palpitations, fatigue, and syncope.

Is post-COVID dysautonomia primarily a heart problem?โ–ผ

No, the paper argues it is primarily a brain-heart-vascular network disorder, with tachycardia being a compensatory response rather than a primary cardiac abnormality.

What are the common clinical phenotypes?โ–ผ

Common phenotypes include postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, orthostatic hypotension, inappropriate sinus tachycardia, and undifferentiated orthostatic intolerance.

How is post-COVID dysautonomia managed?โ–ผ

Management follows a stepwise approach including patient education, trigger avoidance, hydration and salt optimisation, lower-body compression, exercise rehabilitation, pacing strategies, school accommodations, and phenotype-directed pharmacotherapy.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Das B, Moodley M. "Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?." Cardiology in the young, 2026. PMID: 42403377 DOI: 10.1017/S1047951126113900
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.